|
Fund Size
(2.74% of Investment in Category)
|
Expense Ratio
(0.63% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 21-Nov-25 | 10074.20 | 0.74% | - | 0.66% | 12/33 |
| 1 Month | 28-Oct-25 | 10022.10 | 0.22% | - | -0.01% | 16/33 |
| 3 Month | 28-Aug-25 | 10612.10 | 6.12% | - | 4.87% | 11/33 |
| 6 Month | 28-May-25 | 10680.80 | 6.81% | - | 6.07% | 14/32 |
| YTD | 01-Jan-25 | 10483.30 | 4.83% | - | 4.24% | 13/30 |
| 1 Year | 28-Nov-24 | 10754.50 | 7.54% | 7.54% | 4.88% | 6/29 |
| 2 Year | 28-Nov-23 | 14143.60 | 41.44% | 18.90% | 18.71% | 12/24 |
| 3 Year | 28-Nov-22 | 17660.80 | 76.61% | 20.85% | 19.81% | 6/16 |
| 5 Year | 27-Nov-20 | 30652.30 | 206.52% | 25.08% | 22.36% | 2/9 |
| Since Inception | 11-May-17 | 42338.20 | 323.38% | 18.37% | 16.47% | 13/33 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 28-Nov-24 | 12000 | 13033.73 | 8.61 % | 16.26 % |
| 2 Year | 28-Nov-23 | 24000 | 27037.87 | 12.66 % | 11.88 % |
| 3 Year | 28-Nov-22 | 36000 | 47664.72 | 32.4 % | 19.06 % |
| 5 Year | 27-Nov-20 | 60000 | 99425.97 | 65.71 % | 20.28 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Divis Laboratories Ltd. | Pharmaceuticals | 1920.3 | 3.17% | 0.14% | 3.66% (Feb 2025) | 2.97% (Nov 2024) | 2.85 L | -0.20 L |
| ICICI Bank Ltd. | Private sector bank | 1887.5 | 3.12% | -0.19% | 3.63% (Jul 2025) | 1.71% (Jun 2025) | 14.03 L | 0.00 |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1870.4 | 3.09% | -0.29% | 3.48% (Jul 2025) | 0% (Nov 2024) | 9.89 L | 0.00 |
| Indus Towers Ltd. | Telecom - infrastructure | 1632.6 | 2.70% | 0.01% | 3.6% (Apr 2025) | 0% (Nov 2024) | 44.90 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 1498.8 | 2.48% | 0.89% | 2.48% (Oct 2025) | 0% (Nov 2024) | 14.65 L | 5.30 L |
| Ultratech Cement Ltd. | Cement & cement products | 1493.4 | 2.47% | -0.20% | 2.81% (Aug 2025) | 0% (Nov 2024) | 1.25 L | 0.00 |
| Angel One Ltd. | Stockbroking & allied | 1487.2 | 2.46% | 0.95% | 2.46% (Oct 2025) | 0.83% (Feb 2025) | 5.97 L | 1.93 L |
| - Polycab India Limited | Cables - electricals | 1486.9 | 2.46% | 0.00% | 2.46% (Oct 2025) | 0% (Nov 2024) | 1.93 L | 0.00 |
| State Bank Of India | Public sector bank | 1457 | 2.41% | 0.42% | 2.41% (Oct 2025) | 0% (Nov 2024) | 15.55 L | 2.50 L |
| J S W Steel Ltd. | Iron & steel products | 1445.1 | 2.39% | 0.96% | 2.39% (Oct 2025) | 0% (Nov 2024) | 11.98 L | 4.80 L |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 1.85% |
| Net Receivables | Net Receivables | 0.11% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| WhiteOak Capital Multi Cap Fund - Direct Plan - Growth | NA | 2638.72 | 1.21 | 6.83 | 10.20 | 10.66 | 0.00 |
| Mirae Asset Multicap Fund - Direct Plan - Growth | NA | 4388.81 | 0.27 | 6.39 | 8.67 | 9.80 | 0.00 |
| Motilal Oswal Multi Cap Fund - Direct Plan - Growth | NA | 4603.13 | 0.31 | 3.13 | 5.46 | 9.01 | 0.00 |
| Franklin India Multi Cap Fund - Direct Plan - Growth | NA | 5128.67 | 0.36 | 6.45 | 9.47 | 8.37 | 0.00 |
| PGIM India Multi Cap Fund - Direct Plan - Growth | NA | 434.64 | -0.67 | 4.78 | 8.53 | 8.18 | 0.00 |
| Sundaram Multi Cap Fund - Direct Plan - Growth | 3 | 2927.98 | -0.56 | 5.02 | 6.75 | 7.44 | 18.45 |
| Kotak Multicap Fund - Direct Plan - Growth | 4 | 21541.46 | 0.06 | 7.96 | 9.64 | 7.28 | 24.46 |
| Canara Robeco Multi Cap Fund - Direct Plan - Growth | NA | 4902.07 | 0.39 | 4.96 | 6.99 | 6.99 | 0.00 |
| SBI Multicap Fund - Direct Plan - Growth | 3 | 23986.25 | -1.49 | 2.56 | 4.52 | 6.92 | 17.67 |
| Union Multicap Fund - Direct Plan - Growth | NA | 1335.77 | -0.18 | 6.23 | 7.97 | 6.36 | 0.00 |
Out of 25 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 2 is/are ranked 4 * , 6 is/are ranked 3 * , 1 is/are ranked 2 * , 3 is/are ranked 1 * , and 12 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Mahindra Manulife Multi Cap Fund - Direct Plan - Growth | 3 | 6055.38 | 0.22 | 6.12 | 6.81 | 7.54 | 20.85 |
| Mahindra Manulife Small Cap Fund - Direct Plan - Growth | NA | 4307.53 | -2.02 | 4.64 | 6.92 | -0.55 | 0.00 |
| Mahindra Manulife Mid Cap Fund - Direct Plan - Growth | 3 | 4192.44 | 1.02 | 6.08 | 5.43 | 3.17 | 25.42 |
| Mahindra Manulife Large & Mid Cap Fund - Direct Plan - Growth | 1 | 2783.80 | 0.02 | 6.34 | 5.11 | 5.73 | 17.63 |
| Mahindra Manulife Focused Fund - Direct Plan - Growth | 4 | 2207.79 | 0.35 | 6.78 | 5.90 | 7.35 | 20.13 |
| Mahindra Manulife Aggressive Hybrid Fund - Direct Plan - Growth | 5 | 1969.84 | 0.65 | 4.24 | 5.52 | 9.22 | 18.10 |
| Mahindra Manulife Flexi Cap Fund - Direct Plan - Growth | 4 | 1575.38 | 0.81 | 5.69 | 6.03 | 8.60 | 18.37 |
| Mahindra Manulife Business Cycle Fund - Direct Plan - Growth | NA | 1285.41 | 0.94 | 8.26 | 7.49 | 6.71 | 0.00 |
| Mahindra Manulife Liquid Fund - Direct Plan - Growth | 1 | 1044.57 | 0.50 | 1.48 | 3.01 | 6.72 | 7.10 |
| Mahindra Manulife ELSS Tax Saver Fund - Direct Plan - Growth | 3 | 970.35 | 0.82 | 5.25 | 5.55 | 9.11 | 16.18 |